FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890930947> ?p ?o ?g. }

• W2890930947 abstract "Biodegradable polymer sirolimus-eluting stents (BP-SESs) have been reported to be noninferior compared with durable polymer everolimus-eluting stents (DP-EES) in a randomized clinical trial. We sought to compare the efficacy and safety of an ultrathin strut BP-SES with a DP-EES in an all-comers population.Among 7640 consecutive patients who underwent percutaneous coronary intervention between March 2011 and June 2015, 4638 patients were exclusively treated with BP-SES (N=1896; 3137 lesions) or DP-EES (N=2742; 4468 lesions). After propensity score matching within strata of clinical indications, the final study population consisted of 2902 matched patients (BP-SES 2406 lesions and DP-EES 2368 lesions). The primary device-oriented composite end point (DOCE) included cardiac death, target vessel myocardial infarction, and target lesion revascularization at 1 year. BP-SES (6.9%) was noninferior to DP-EES (8.0%) with respect to device-oriented composite end point (hazard ratio [HR], 0.85; 95% CI, 0.65-1.11; P for noninferiority <0.001; P for superiority=0.24). No differences in cardiac death (BP-SES, 2.3% versus DP-EES, 3.0%; HR, 0.76; 95% CI, 0.49-1.20; P=0.25), myocardial infarction (BP-SES, 4.6% versus DP-EES, 4.6%; HR, 1.00; 95% CI, 0.71-1.40; P=0.99), or target lesion revascularization (BP-SES, 2.8% versus DP-EES, 2.5%; HR, 1.11; 95% CI, 0.71-1.74; P=0.65) were observed. The rate of periprocedural myocardial infarction was comparable between the 2 groups (2.1% versus 2.2%; HR, 0.97; 95% CI, 0.59-1.58; P=0.89). The rate of definite stent thrombosis was similarly low throughout 1 year (BP-SES, 0.8% versus DP-EES, 0.8%; HR, 1.00; 95% CI, 0.45-2.22; P=1.00).In a consecutively enrolled percutaneous coronary intervention population reflecting routine clinical practice, BP-SES was noninferior to DP-EES for device-oriented composite end point at 1 year.URL: https://www.clinicaltrials.gov . Unique identifier: NCT02241291." @default.
• W2890930947 created "2018-09-27" @default.
• W2890930947 creator A5000190765 @default.
• W2890930947 creator A5002027683 @default.
• W2890930947 creator A5019587141 @default.
• W2890930947 creator A5032028897 @default.
• W2890930947 creator A5038358378 @default.
• W2890930947 creator A5040134218 @default.
• W2890930947 creator A5040786618 @default.
• W2890930947 creator A5042111387 @default.
• W2890930947 creator A5044884884 @default.
• W2890930947 creator A5047690226 @default.
• W2890930947 creator A5048697529 @default.
• W2890930947 creator A5051530432 @default.
• W2890930947 creator A5052058613 @default.
• W2890930947 creator A5053194091 @default.
• W2890930947 creator A5064844092 @default.
• W2890930947 creator A5066050469 @default.
• W2890930947 creator A5066913399 @default.
• W2890930947 date "2018-09-01" @default.
• W2890930947 modified "2023-09-24" @default.
• W2890930947 title "Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization" @default.
• W2890930947 cites W1032315853 @default.
• W2890930947 cites W1840021307 @default.
• W2890930947 cites W1921048136 @default.
• W2890930947 cites W1922239974 @default.
• W2890930947 cites W1997760014 @default.
• W2890930947 cites W2000590814 @default.
• W2890930947 cites W2029603191 @default.
• W2890930947 cites W2079612181 @default.
• W2890930947 cites W2087150869 @default.
• W2890930947 cites W2138514916 @default.
• W2890930947 cites W2146743728 @default.
• W2890930947 cites W2161895979 @default.
• W2890930947 cites W2233380747 @default.
• W2890930947 cites W2238136941 @default.
• W2890930947 cites W2298156623 @default.
• W2890930947 cites W2346565584 @default.
• W2890930947 cites W2517020747 @default.
• W2890930947 cites W2546366038 @default.
• W2890930947 cites W2547759268 @default.
• W2890930947 cites W2747702104 @default.
• W2890930947 cites W2768414624 @default.
• W2890930947 cites W2887297392 @default.
• W2890930947 cites W4211143229 @default.
• W2890930947 cites W4236531408 @default.
• W2890930947 doi "https://doi.org/10.1161/circinterventions.118.006741" @default.
• W2890930947 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354590" @default.
• W2890930947 hasPublicationYear "2018" @default.
• W2890930947 type Work @default.
• W2890930947 sameAs 2890930947 @default.
• W2890930947 citedByCount "12" @default.
• W2890930947 countsByYear W28909309472018 @default.
• W2890930947 countsByYear W28909309472019 @default.
• W2890930947 countsByYear W28909309472020 @default.
• W2890930947 countsByYear W28909309472021 @default.
• W2890930947 countsByYear W28909309472023 @default.
• W2890930947 crossrefType "journal-article" @default.
• W2890930947 hasAuthorship W2890930947A5000190765 @default.
• W2890930947 hasAuthorship W2890930947A5002027683 @default.
• W2890930947 hasAuthorship W2890930947A5019587141 @default.
• W2890930947 hasAuthorship W2890930947A5032028897 @default.
• W2890930947 hasAuthorship W2890930947A5038358378 @default.
• W2890930947 hasAuthorship W2890930947A5040134218 @default.
• W2890930947 hasAuthorship W2890930947A5040786618 @default.
• W2890930947 hasAuthorship W2890930947A5042111387 @default.
• W2890930947 hasAuthorship W2890930947A5044884884 @default.
• W2890930947 hasAuthorship W2890930947A5047690226 @default.
• W2890930947 hasAuthorship W2890930947A5048697529 @default.
• W2890930947 hasAuthorship W2890930947A5051530432 @default.
• W2890930947 hasAuthorship W2890930947A5052058613 @default.
• W2890930947 hasAuthorship W2890930947A5053194091 @default.
• W2890930947 hasAuthorship W2890930947A5064844092 @default.
• W2890930947 hasAuthorship W2890930947A5066050469 @default.
• W2890930947 hasAuthorship W2890930947A5066913399 @default.
• W2890930947 hasBestOaLocation W28909309471 @default.
• W2890930947 hasConcept C126322002 @default.
• W2890930947 hasConcept C141071460 @default.
• W2890930947 hasConcept C164705383 @default.
• W2890930947 hasConcept C17923572 @default.
• W2890930947 hasConcept C207103383 @default.
• W2890930947 hasConcept C2777921159 @default.
• W2890930947 hasConcept C2778583881 @default.
• W2890930947 hasConcept C2779464278 @default.
• W2890930947 hasConcept C2779699572 @default.
• W2890930947 hasConcept C2780400711 @default.
• W2890930947 hasConcept C2781464078 @default.
• W2890930947 hasConcept C2908647359 @default.
• W2890930947 hasConcept C44249647 @default.
• W2890930947 hasConcept C500558357 @default.
• W2890930947 hasConcept C71924100 @default.
• W2890930947 hasConcept C99454951 @default.
• W2890930947 hasConceptScore W2890930947C126322002 @default.
• W2890930947 hasConceptScore W2890930947C141071460 @default.
• W2890930947 hasConceptScore W2890930947C164705383 @default.
• W2890930947 hasConceptScore W2890930947C17923572 @default.
• W2890930947 hasConceptScore W2890930947C207103383 @default.
• W2890930947 hasConceptScore W2890930947C2777921159 @default.
• W2890930947 hasConceptScore W2890930947C2778583881 @default.
• W2890930947 hasConceptScore W2890930947C2779464278 @default.

• next